Searchable abstracts of presentations at key conferences in endocrinology

ea0081p92 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Transforming growth factor beta 1: a new factor reducing hepatic sex hormone binding globulin production during liver fibrosis development

Brianso Llort Laura , Fuertes Rioja Lidia , Ramos Perez Lorena , Salcedo Allende Maria Teresa , Hernandez Cristina , Canonge Rafael Simo , Martinez David

Low plasma sex hormone-binding globulin (SHBG) levels are present in fatty liver disease, which represent a spectrum of diseases ranging from hepatocellular steatosis through steatohepatitis to fibrosis and irreversible cirrhosis. We have previously determined that fat accumulation reduces SHBG production in different non-alcoholic fatty liver disease (NAFLD) mouse models and that SHBG plays an active role in the development of this disease. In the present work, we are interes...

ea0073ep88 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Rooibos tea (Aspalathus linearis) upregulates hepatic sex hormone-binding globulin production

Laura Briansó Llort , Pheiffer Carmen , Fuertes Rioja Lidia , Ramos Perez Lorena , Hernandez Cristina , Simo Canonge Rafael , Martinez David

Sex hormone-binding globulin (SHBG) is a circulating plasma glycoprotein produced by the liver, which in the blood binds estrogens and androgens with high affinity and regulates its bioavailability. Low plasma SHBG levels are associated with obesity, metabolic syndrome and non-alcoholic fatty liver disease. Importantly, epidemiological studies have demonstrated that low plasma SHBG levels is a risk factor for developing type 2 diabetes and cardiovascular disease. In the last y...